← back to search

Kathleen Speck

Johns Hopkins University · US
Area of research
Applied Microbiology and Biotechnology · Critical Care and Intensive Care Medicine
Research interest
Research interests include Antibiotic Use and Resistance, Nosocomial Infections in ICU, Infection Control in Healthcare, and Respiratory Support and Mechanisms.
h-index
19
citations
2,812
works
41
NIH funding
primary concept
email

Recent publications

Strategies to prevent ventilator-associated pneumonia, ventilator-associated events, and nonventilator hospital-acquired pneumonia in acute-care hospitals: 2022 Update
Infection Control and Hospital Epidemiology 2022cited by 327position: middledoi
Implementation of an Antibiotic Stewardship Program in Long-term Care Facilities Across the US
JAMA Network Open 2022cited by 32position: middledoi
Assessment of Changes in Visits and Antibiotic Prescribing During the Agency for Healthcare Research and Quality Safety Program for Improving Antibiotic Use and the COVID-19 Pandemic
JAMA Network Open 2022cited by 19position: middledoi
Association of a Safety Program for Improving Antibiotic Use With Antibiotic Use and Hospital-Onset <i>Clostridioides difficile</i> Infection Rates Among US Hospitals
JAMA Network Open 2021cited by 32position: middledoi
The inconvincible patient: how clinicians perceive demand for antibiotics in the outpatient setting
Family Practice 2019cited by 89position: middledoi
Strategies to Prevent Ventilator-Associated Pneumonia in Acute Care Hospitals: 2014 Update
Infection Control and Hospital Epidemiology 2014cited by 424position: middledoi
Reappraisal of Routine Oral Care With Chlorhexidine Gluconate for Patients Receiving Mechanical Ventilation
JAMA Internal Medicine 2014cited by 307position: middledoi
Strategies to Prevent Ventilator-Associated Pneumonia in Acute Care Hospitals: 2014 Update
Infection Control and Hospital Epidemiology 2014cited by 195position: middledoi
Daily chlorhexidine bathing to reduce bacteraemia in critically ill children: a multicentre, cluster-randomised, crossover trial
The Lancet 2013cited by 218position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Linda Greene · Imperial College Healthcare NHS Trust4 papers (2014–2022)Melissa A. Miller · University of Fort Lauderdale4 papers (2019–2022)Roy Ahn · Chicago Department of Public Health4 papers (2019–2022)Sean M. Berenholtz · Johns Hopkins University4 papers (2014–2022)Sara E. Cosgrove · University of Baltimore4 papers (2019–2022)Michael Klompas · Harvard University4 papers (2014–2022)Pranita D. Tamma · Johns Hopkins University4 papers (2019–2022)Richard D. Branson · The University of Texas Medical Branch at Galveston3 papers (2014–2022)Deborah S. Yokoe · University of California San Francisco Medical Center3 papers (2014–2022) · 3 papers (2014–2022)Eric C. Eichenwald · University of Pennsylvania3 papers (2014–2022)Lisa L. Maragakis · Johns Hopkins University3 papers (2014–2022)Michael D. Howell · The Francis Crick Institute3 papers (2014–2014)Grace Lee · University of Arizona2 papers (2014–2014)Sara C. Keller · Johns Hopkins Medicine2 papers (2019–2022)Shelley S. Magill · Centers for Disease Control and Prevention2 papers (2014–2014)Savyasachi V. Shah · University of Chicago2 papers (2022–2022)Jeffrey A. Linder · Northwestern University2 papers (2019–2022)Morgan J. Katz · Christiana Care Health System1 papers (2022–2022) · 1 papers (2013–2013)